 | • レポートコード：GIR-2104Z00975 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、真菌感染症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。真菌感染症治療薬の種類別市場規模（ポリエン、エキノカンジン、アゾール、アリルアミン、その他薬剤）、用途別市場規模（粉末、ペースト、軟膏、医薬品、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・真菌感染症治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Scynexis、Sanofi-Aventis、Pfizer、Novartis、Merck & Co、Kramer Laboratories、Johnson & Johnson、ID Sigma-Aldrich Corporation、Glenmark Pharmaceuticals、Glaxosmithkline、Enzon Pharmaceuticals、Bayer Healthcare、Astellas Pharma、Asperqillus、Alternaria、Abbott Laboratories ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ポリエン、エキノカンジン、アゾール、アリルアミン、その他薬剤 ・用途別分析2016年-2026年：粉末、ペースト、軟膏、医薬品、その他 ・真菌感染症治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・真菌感染症治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・真菌感染症治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・真菌感染症治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・真菌感染症治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Antifungal infection Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Antifungal infection Therapeutics size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Antifungal infection Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Antifungal infection Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Polyenes
Echinocandins
Azoles
Allylamines
Other Drug types
Market segment by Application, can be divided into
Powders
Pastes
Ointments
Drugs
Other Applications
Market segment by players, this report covers
Scynexis
Sanofi-Aventis
Pfizer
Novartis
Merck & Co
Kramer Laboratories
Johnson & Johnson
ID Sigma-Aldrich Corporation
Glenmark Pharmaceuticals
Glaxosmithkline
Enzon Pharmaceuticals
Bayer Healthcare
Astellas Pharma
Asperqillus
Alternaria
Abbott Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Antifungal infection Therapeutics
1.2 Classification of Antifungal infection Therapeutics by Type
1.2.1 Overview: Global Antifungal infection Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Antifungal infection Therapeutics Revenue Market Share by Type in 2020
1.2.3 Polyenes
1.2.4 Echinocandins
1.2.5 Azoles
1.2.6 Allylamines
1.2.7 Other Drug types
1.3 Global Antifungal infection Therapeutics Market by Application
1.3.1 Overview: Global Antifungal infection Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Powders
1.3.3 Pastes
1.3.4 Ointments
1.3.5 Drugs
1.3.6 Other Applications
1.4 Global Antifungal infection Therapeutics Market Size & Forecast
1.5 Global Antifungal infection Therapeutics Market Size and Forecast by Region
1.5.1 Global Antifungal infection Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Antifungal infection Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Antifungal infection Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Antifungal infection Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Antifungal infection Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Antifungal infection Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Antifungal infection Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Antifungal infection Therapeutics Market Drivers
1.6.2 Antifungal infection Therapeutics Market Restraints
1.6.3 Antifungal infection Therapeutics Trends Analysis
2 Company Profiles
2.1 Scynexis
2.1.1 Scynexis Details
2.1.2 Scynexis Major Business
2.1.3 Scynexis Antifungal infection Therapeutics Product and Solutions
2.1.4 Scynexis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Scynexis Recent Developments and Future Plans
2.2 Sanofi-Aventis
2.2.1 Sanofi-Aventis Details
2.2.2 Sanofi-Aventis Major Business
2.2.3 Sanofi-Aventis Antifungal infection Therapeutics Product and Solutions
2.2.4 Sanofi-Aventis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Sanofi-Aventis Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Antifungal infection Therapeutics Product and Solutions
2.3.4 Pfizer Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Antifungal infection Therapeutics Product and Solutions
2.4.4 Novartis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Merck & Co
2.5.1 Merck & Co Details
2.5.2 Merck & Co Major Business
2.5.3 Merck & Co Antifungal infection Therapeutics Product and Solutions
2.5.4 Merck & Co Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Merck & Co Recent Developments and Future Plans
2.6 Kramer Laboratories
2.6.1 Kramer Laboratories Details
2.6.2 Kramer Laboratories Major Business
2.6.3 Kramer Laboratories Antifungal infection Therapeutics Product and Solutions
2.6.4 Kramer Laboratories Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Kramer Laboratories Recent Developments and Future Plans
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Antifungal infection Therapeutics Product and Solutions
2.7.4 Johnson & Johnson Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Johnson & Johnson Recent Developments and Future Plans
2.8 ID Sigma-Aldrich Corporation
2.8.1 ID Sigma-Aldrich Corporation Details
2.8.2 ID Sigma-Aldrich Corporation Major Business
2.8.3 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Product and Solutions
2.8.4 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 ID Sigma-Aldrich Corporation Recent Developments and Future Plans
2.9 Glenmark Pharmaceuticals
2.9.1 Glenmark Pharmaceuticals Details
2.9.2 Glenmark Pharmaceuticals Major Business
2.9.3 Glenmark Pharmaceuticals Antifungal infection Therapeutics Product and Solutions
2.9.4 Glenmark Pharmaceuticals Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Glenmark Pharmaceuticals Recent Developments and Future Plans
2.10 Glaxosmithkline
2.10.1 Glaxosmithkline Details
2.10.2 Glaxosmithkline Major Business
2.10.3 Glaxosmithkline Antifungal infection Therapeutics Product and Solutions
2.10.4 Glaxosmithkline Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Glaxosmithkline Recent Developments and Future Plans
2.11 Enzon Pharmaceuticals
2.11.1 Enzon Pharmaceuticals Details
2.11.2 Enzon Pharmaceuticals Major Business
2.11.3 Enzon Pharmaceuticals Antifungal infection Therapeutics Product and Solutions
2.11.4 Enzon Pharmaceuticals Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Enzon Pharmaceuticals Recent Developments and Future Plans
2.12 Bayer Healthcare
2.12.1 Bayer Healthcare Details
2.12.2 Bayer Healthcare Major Business
2.12.3 Bayer Healthcare Antifungal infection Therapeutics Product and Solutions
2.12.4 Bayer Healthcare Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Bayer Healthcare Recent Developments and Future Plans
2.13 Astellas Pharma
2.13.1 Astellas Pharma Details
2.13.2 Astellas Pharma Major Business
2.13.3 Astellas Pharma Antifungal infection Therapeutics Product and Solutions
2.13.4 Astellas Pharma Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Astellas Pharma Recent Developments and Future Plans
2.14 Asperqillus
2.14.1 Asperqillus Details
2.14.2 Asperqillus Major Business
2.14.3 Asperqillus Antifungal infection Therapeutics Product and Solutions
2.14.4 Asperqillus Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Asperqillus Recent Developments and Future Plans
2.15 Alternaria
2.15.1 Alternaria Details
2.15.2 Alternaria Major Business
2.15.3 Alternaria Antifungal infection Therapeutics Product and Solutions
2.15.4 Alternaria Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Alternaria Recent Developments and Future Plans
2.16 Abbott Laboratories
2.16.1 Abbott Laboratories Details
2.16.2 Abbott Laboratories Major Business
2.16.3 Abbott Laboratories Antifungal infection Therapeutics Product and Solutions
2.16.4 Abbott Laboratories Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Abbott Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Antifungal infection Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Antifungal infection Therapeutics Players Market Share
3.2.2 Top 10 Antifungal infection Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Antifungal infection Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Antifungal infection Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Antifungal infection Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Antifungal infection Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Antifungal infection Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Antifungal infection Therapeutics Revenue by Type (2016-2026)
6.2 North America Antifungal infection Therapeutics Revenue by Application (2016-2026)
6.3 North America Antifungal infection Therapeutics Market Size by Country
6.3.1 North America Antifungal infection Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Antifungal infection Therapeutics Revenue by Type (2016-2026)
7.2 Europe Antifungal infection Therapeutics Revenue by Application (2016-2026)
7.3 Europe Antifungal infection Therapeutics Market Size by Country
7.3.1 Europe Antifungal infection Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Antifungal infection Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Antifungal infection Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Antifungal infection Therapeutics Market Size by Region
8.3.1 Asia-Pacific Antifungal infection Therapeutics Revenue by Region (2016-2026)
8.3.2 China Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Antifungal infection Therapeutics Revenue by Type (2016-2026)
9.2 South America Antifungal infection Therapeutics Revenue by Application (2016-2026)
9.3 South America Antifungal infection Therapeutics Market Size by Country
9.3.1 South America Antifungal infection Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Antifungal infection Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Antifungal infection Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Antifungal infection Therapeutics Market Size by Country
10.3.1 Middle East & Africa Antifungal infection Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Antifungal infection Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Antifungal infection Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Antifungal infection Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Antifungal infection Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Antifungal infection Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Antifungal infection Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Scynexis Corporate Information, Head Office, and Major Competitors
Table 7. Scynexis Major Business
Table 8. Scynexis Antifungal infection Therapeutics Product and Solutions
Table 9. Scynexis Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Sanofi-Aventis Corporate Information, Head Office, and Major Competitors
Table 11. Sanofi-Aventis Major Business
Table 12. Sanofi-Aventis Antifungal infection Therapeutics Product and Solutions
Table 13. Sanofi-Aventis Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Pfizer Corporate Information, Head Office, and Major Competitors
Table 15. Pfizer Major Business
Table 16. Pfizer Antifungal infection Therapeutics Product and Solutions
Table 17. Pfizer Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Novartis Corporate Information, Head Office, and Major Competitors
Table 19. Novartis Major Business
Table 20. Novartis Antifungal infection Therapeutics Product and Solutions
Table 21. Novartis Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Merck & Co Corporate Information, Head Office, and Major Competitors
Table 23. Merck & Co Major Business
Table 24. Merck & Co Antifungal infection Therapeutics Product and Solutions
Table 25. Merck & Co Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Kramer Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. Kramer Laboratories Major Business
Table 28. Kramer Laboratories Antifungal infection Therapeutics Product and Solutions
Table 29. Kramer Laboratories Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 31. Johnson & Johnson Major Business
Table 32. Johnson & Johnson Antifungal infection Therapeutics Product and Solutions
Table 33. Johnson & Johnson Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. ID Sigma-Aldrich Corporation Corporate Information, Head Office, and Major Competitors
Table 35. ID Sigma-Aldrich Corporation Major Business
Table 36. ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Product and Solutions
Table 37. ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Glenmark Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. Glenmark Pharmaceuticals Major Business
Table 40. Glenmark Pharmaceuticals Antifungal infection Therapeutics Product and Solutions
Table 41. Glenmark Pharmaceuticals Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Glaxosmithkline Corporate Information, Head Office, and Major Competitors
Table 43. Glaxosmithkline Major Business
Table 44. Glaxosmithkline Antifungal infection Therapeutics Product and Solutions
Table 45. Glaxosmithkline Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Enzon Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 47. Enzon Pharmaceuticals Major Business
Table 48. Enzon Pharmaceuticals Antifungal infection Therapeutics Product and Solutions
Table 49. Enzon Pharmaceuticals Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Bayer Healthcare Corporate Information, Head Office, and Major Competitors
Table 51. Bayer Healthcare Major Business
Table 52. Bayer Healthcare Antifungal infection Therapeutics Product and Solutions
Table 53. Bayer Healthcare Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 55. Astellas Pharma Major Business
Table 56. Astellas Pharma Antifungal infection Therapeutics Product and Solutions
Table 57. Astellas Pharma Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Asperqillus Corporate Information, Head Office, and Major Competitors
Table 59. Asperqillus Major Business
Table 60. Asperqillus Antifungal infection Therapeutics Product and Solutions
Table 61. Asperqillus Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Alternaria Corporate Information, Head Office, and Major Competitors
Table 63. Alternaria Major Business
Table 64. Alternaria Antifungal infection Therapeutics Product and Solutions
Table 65. Alternaria Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 67. Abbott Laboratories Major Business
Table 68. Abbott Laboratories Antifungal infection Therapeutics Product and Solutions
Table 69. Abbott Laboratories Antifungal infection Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Global Antifungal infection Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 71. Global Antifungal infection Therapeutics Revenue Share by Players (2019-2021)
Table 72. Breakdown of Antifungal infection Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Antifungal infection Therapeutics Players Head Office, Products and Services Provided
Table 74. Antifungal infection Therapeutics Mergers & Acquisitions in the Past Five Years
Table 75. Antifungal infection Therapeutics New Entrants and Expansion Plans
Table 76. Global Antifungal infection Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 77. Global Antifungal infection Therapeutics Revenue Share by Type (2016-2021)
Table 78. Global Antifungal infection Therapeutics Revenue Forecast by Type (2021-2026)
Table 79. Global Antifungal infection Therapeutics Revenue by Application (2016-2021)
Table 80. Global Antifungal infection Therapeutics Revenue Forecast by Application (2021-2026)
Table 81. North America Antifungal infection Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 82. North America Antifungal infection Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 83. North America Antifungal infection Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 84. North America Antifungal infection Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 85. North America Antifungal infection Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 86. North America Antifungal infection Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 87. Europe Antifungal infection Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 88. Europe Antifungal infection Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 89. Europe Antifungal infection Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 90. Europe Antifungal infection Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 91. Europe Antifungal infection Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 92. Europe Antifungal infection Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 93. Asia-Pacific Antifungal infection Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 94. Asia-Pacific Antifungal infection Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 95. Asia-Pacific Antifungal infection Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 96. Asia-Pacific Antifungal infection Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 97. Asia-Pacific Antifungal infection Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 98. Asia-Pacific Antifungal infection Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 99. South America Antifungal infection Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 100. South America Antifungal infection Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 101. South America Antifungal infection Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 102. South America Antifungal infection Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 103. South America Antifungal infection Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 104. South America Antifungal infection Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 105. Middle East & Africa Antifungal infection Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 106. Middle East & Africa Antifungal infection Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 107. Middle East & Africa Antifungal infection Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 108. Middle East & Africa Antifungal infection Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 109. Middle East & Africa Antifungal infection Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 110. Middle East & Africa Antifungal infection Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Antifungal infection Therapeutics Picture
Figure 2. Global Antifungal infection Therapeutics Revenue Market Share by Type in 2020
Figure 3. Polyenes
Figure 4. Echinocandins
Figure 5. Azoles
Figure 6. Allylamines
Figure 7. Other Drug types
Figure 8. Antifungal infection Therapeutics Revenue Market Share by Application in 2020
Figure 9. Powders Picture
Figure 10. Pastes Picture
Figure 11. Ointments Picture
Figure 12. Drugs Picture
Figure 13. Other Applications Picture
Figure 14. Global Antifungal infection Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Antifungal infection Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Antifungal infection Therapeutics Revenue Market Share by Region (2016-2026)
Figure 17. Global Antifungal infection Therapeutics Revenue Market Share by Region in 2020
Figure 18. North America Antifungal infection Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Antifungal infection Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Antifungal infection Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Antifungal infection Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Antifungal infection Therapeutics Market Drivers
Figure 23. Antifungal infection Therapeutics Market Restraints
Figure 24. Antifungal infection Therapeutics Market Trends
Figure 25. Scynexis Recent Developments and Future Plans
Figure 26. Sanofi-Aventis Recent Developments and Future Plans
Figure 27. Pfizer Recent Developments and Future Plans
Figure 28. Novartis Recent Developments and Future Plans
Figure 29. Merck & Co Recent Developments and Future Plans
Figure 30. Kramer Laboratories Recent Developments and Future Plans
Figure 31. Johnson & Johnson Recent Developments and Future Plans
Figure 32. ID Sigma-Aldrich Corporation Recent Developments and Future Plans
Figure 33. Glenmark Pharmaceuticals Recent Developments and Future Plans
Figure 34. Glaxosmithkline Recent Developments and Future Plans
Figure 35. Enzon Pharmaceuticals Recent Developments and Future Plans
Figure 36. Bayer Healthcare Recent Developments and Future Plans
Figure 37. Astellas Pharma Recent Developments and Future Plans
Figure 38. Asperqillus Recent Developments and Future Plans
Figure 39. Alternaria Recent Developments and Future Plans
Figure 40. Abbott Laboratories Recent Developments and Future Plans
Figure 42. Global Antifungal infection Therapeutics Revenue Share by Players in 2020
Figure 43. Antifungal infection Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 44. Global Top 3 Players Antifungal infection Therapeutics Revenue Market Share in 2020
Figure 45. Global Top 10 Players Antifungal infection Therapeutics Revenue Market Share in 2020
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 47. Global Antifungal infection Therapeutics Revenue Share by Type in 2020
Figure 48. Global Antifungal infection Therapeutics Market Share Forecast by Type (2021-2026)
Figure 49. Global Antifungal infection Therapeutics Revenue Share by Application in 2020
Figure 50. Global Antifungal infection Therapeutics Market Share Forecast by Application (2021-2026)
Figure 51. North America Antifungal infection Therapeutics Sales Market Share by Type (2016-2026)
Figure 52. North America Antifungal infection Therapeutics Sales Market Share by Application (2016-2026)
Figure 53. North America Antifungal infection Therapeutics Revenue Market Share by Country (2016-2026)
Figure 54. United States Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Canada Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Mexico Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Europe Antifungal infection Therapeutics Sales Market Share by Type (2016-2026)
Figure 58. Europe Antifungal infection Therapeutics Sales Market Share by Application (2016-2026)
Figure 59. Europe Antifungal infection Therapeutics Revenue Market Share by Country (2016-2026)
Figure 60. Germany Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. France Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. United Kingdom Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Russia Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Italy Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Asia-Pacific Antifungal infection Therapeutics Sales Market Share by Type (2016-2026)
Figure 66. Asia-Pacific Antifungal infection Therapeutics Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Antifungal infection Therapeutics Revenue Market Share by Region (2016-2026)
Figure 68. China Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Japan Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South Korea Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. India Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Southeast Asia Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Australia Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South America Antifungal infection Therapeutics Sales Market Share by Type (2016-2026)
Figure 75. South America Antifungal infection Therapeutics Sales Market Share by Application (2016-2026)
Figure 76. South America Antifungal infection Therapeutics Revenue Market Share by Country (2016-2026)
Figure 77. Brazil Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Argentina Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Middle East and Africa Antifungal infection Therapeutics Sales Market Share by Type (2016-2026)
Figure 80. Middle East and Africa Antifungal infection Therapeutics Sales Market Share by Application (2016-2026)
Figure 81. Middle East and Africa Antifungal infection Therapeutics Revenue Market Share by Country (2016-2026)
Figure 82. Turkey Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Saudi Arabia Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. UAE Antifungal infection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source
世界の抗真菌感染症治療市場規模・現状・予測（2021年-2027年） Antifungal drugs are used to treat infections caused by fungus and to prevent the development of fungal infections in patients with weakened immune systems. Market Analysis and Insights: Global Antifungal infection Therapeutics Market The global Antifungal infection Therapeutics market size is proje…- 世界の院内感染症治療市場規模・現状・予測（2021年-2027年） Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infec…
- 世界のペプチドベース感染症治療薬市場規模・現状・予測（2021年-2027年） Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective. Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market. Market Analysis and Insights: Global Peptide Based Infection Therapeutics Market The global Peptide …
- 世界のクラミジア感染症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chlamydia Infection Therapeutics Market The global Chlamydia Infection Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
- 世界のクラミジア感染症診断・治療市場規模・現状・予測（2021年-2027年） The chlamydia infection diagnostics and therapeutics market unveils high potential owing to the rapidly rising patient pool and vast untapped opportunities. Market Analysis and Insights: Global Chlamydia Infection Diagnostics and Therapeutics Market The global Chlamydia Infection Diagnostics and The…